All In Biotech

Free tool

FAERS Monitor: Sporanox

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020083 or its brand name (Sporanox, Itraconazole). Reports on generic versions are filed under their own applications.

Reports

11,784

Serious

10,489

89% of reports

Hospitalization

4,471

Death reported

2,277

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug interaction1,191
  • drug ineffective1,144
  • off label use632
  • pyrexia589
  • dyspnoea493
  • pneumonia484
  • nausea468
  • diarrhoea404
  • condition aggravated400
  • febrile neutropenia373
  • fatigue351
  • rash310
  • anaemia303
  • neutropenia302
  • cough295

Reports by year received

View as table
YearReports
2004277
2005192
2006219
2007254
2008291
2009408
2010361
2011621
2012587
2013409
2014373
2015610
2016474
2017517
2018703
2019826
2020868
2021782
2022676
2023676
2024601
2025566
2026492

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,375 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug interactionSignal1,19113.512.813,765
febrile neutropeniaSignal37310.19.13,037
neutropeniaSignal3024.03.6671
pyrexiaSignal5893.02.8817
anaemiaSignal3032.82.5362
pneumoniaSignal4842.72.4511
condition aggravatedSignal4002.42.1313
cough2951.91.7122
dyspnoea4931.61.4100
drug ineffective1,1441.51.5237
off label use6321.31.242
rash3101.31.118
diarrhoea4041.11.05
nausea4681.11.01
fatigue3510.80.717

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.